GlassScriptPhysician profile
William M Weiss
NPI 1053755454
$5,142.29
in general payments reported to CMS, 2019-2025
15 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,728 · 2020: $397 · 2021: $403 · 2022: $269 · 2023: $509 · 2024: $677 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.13 |
| Travel and Lodging | $397.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,084.17 | 2019-2025 | Mako, Triathlon, T2 Alpha |
| Tetraphase Pharmaceuticals, INC. | $1,500.00 | 2019 | |
| Arthrex, INC. | $397.91 | 2025 | |
| Depuy Synthes Sales INC. | $338.73 | 2019-2025 | Na, Va-Lcp |
| Smith+Nephew, INC. | $246.43 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System |
| Acera Surgical, INC. | $242.78 | 2024-2025 | Restrata Wound Matrix |
| Alafair Biosciences, INC. | $157.60 | 2025 | Versawrap |
| 4web, INC. | $31.25 | 2019 | |
| Heron Therapeutics, INC. | $24.46 | 2024 | Zynrelef |
| Orthalign INC | $23.46 | 2025 | Orthalign Plus |
| Bioventus LLC | $22.57 | 2021 | |
| Kerecis Limited | $19.48 | 2020 | |
| Pfizer INC. | $18.61 | 2024 | |
| Medinc of Texas | $17.73 | 2022 | |
| Integra Lifesciences Corporation | $17.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.